FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893162207> ?p ?o ?g. }

• W2893162207 endingPage "23" @default.
• W2893162207 startingPage "17" @default.
• W2893162207 abstract "Objectives: To investigate whether smoking habits predict response to rituximab (RTX) in rheumatoid arthritis (RA).Method: We included patients from the CERERRA international cohort receiving the first treatment cycle with available smoking status (n = 2481, smokers n = 528, non-current smokers n = 1953) and at least one follow-up visit. Outcome measures were change in Disease Activity Score based on 28-joint count (ΔDAS28) and European League Against Rheumatism (EULAR) good response at 6 months, with non-current smokers as the referent group.Results: Compared with non-smokers at baseline, smokers were more often rheumatoid factor (RF)/anti-citrullinated protein antibody (ACPA) positive and males, had shorter disease duration, lower DAS28 and Health Assessment Questionnaire (HAQ) score, a higher number of prior biological disease-modifying anti-rheumatic drugs, and were more likely to receive concomitant conventional synthetic disease-modifying anti-rheumatic drug (csDMARDs). Disease activity had decreased less in smokers at 6 months (ΔDAS28 = 1.5 vs 1.7, p = 0.006), although the difference was no longer significant after correction for baseline DAS28 (p = 0.41). EULAR good response rates did not differ between smokers and non-smokers overall or stratified by RF/ACPA status, although smokers had lower good response rates among seronegative patients (ACPA-negative: 6% vs 14%, RF-negative: 11% vs 18%). Smoking did not predict good response [odds ratio (OR) = 1.04, 95% confidence interval (CI) = 0.76–1.41], while ACPA, DAS28, HAQ, and concomitant csDMARDs were significant predictors for good response. However, when stratified by country, smokers were less likely to achieve good response in Sweden (unadjusted OR = 0.24, 95% CI = 0.07–0.89), and a trend was seen in the Czech Republic (OR = 0.45, 95% CI = 0.16–1.02).Conclusion: In this large, observational, multinational RA cohort, smokers starting RTX differed from non-smokers by having shorter disease duration and lower disease activity, but more previous treatments. The overall results do not support smoking as an important predictor for response to RTX in patients with RA." @default.
• W2893162207 created "2018-10-05" @default.
• W2893162207 creator A5000798254 @default.
• W2893162207 creator A5012009272 @default.
• W2893162207 creator A5021089252 @default.
• W2893162207 creator A5024484324 @default.
• W2893162207 creator A5035671675 @default.
• W2893162207 creator A5039628338 @default.
• W2893162207 creator A5043580027 @default.
• W2893162207 creator A5048248640 @default.
• W2893162207 creator A5049547284 @default.
• W2893162207 creator A5063586848 @default.
• W2893162207 creator A5073320477 @default.
• W2893162207 creator A5083882610 @default.
• W2893162207 creator A5087803133 @default.
• W2893162207 creator A5089477356 @default.
• W2893162207 date "2018-09-27" @default.
• W2893162207 modified "2023-10-17" @default.
• W2893162207 title "Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration" @default.
• W2893162207 cites W2023597726 @default.
• W2893162207 cites W2024644107 @default.
• W2893162207 cites W2025408360 @default.
• W2893162207 cites W2052047947 @default.
• W2893162207 cites W2077158310 @default.
• W2893162207 cites W2077882848 @default.
• W2893162207 cites W2094231073 @default.
• W2893162207 cites W2099260383 @default.
• W2893162207 cites W2118994799 @default.
• W2893162207 cites W2123556713 @default.
• W2893162207 cites W2130631271 @default.
• W2893162207 cites W2131280252 @default.
• W2893162207 cites W2132841358 @default.
• W2893162207 cites W2133205391 @default.
• W2893162207 cites W2142219725 @default.
• W2893162207 cites W2148107277 @default.
• W2893162207 cites W2153721587 @default.
• W2893162207 cites W2165459235 @default.
• W2893162207 cites W2278084370 @default.
• W2893162207 cites W2410237939 @default.
• W2893162207 doi "https://doi.org/10.1080/03009742.2018.1466363" @default.
• W2893162207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30260261" @default.
• W2893162207 hasPublicationYear "2018" @default.
• W2893162207 type Work @default.
• W2893162207 sameAs 2893162207 @default.
• W2893162207 citedByCount "5" @default.
• W2893162207 countsByYear W28931622072019 @default.
• W2893162207 countsByYear W28931622072020 @default.
• W2893162207 countsByYear W28931622072022 @default.
• W2893162207 crossrefType "journal-article" @default.
• W2893162207 hasAuthorship W2893162207A5000798254 @default.
• W2893162207 hasAuthorship W2893162207A5012009272 @default.
• W2893162207 hasAuthorship W2893162207A5021089252 @default.
• W2893162207 hasAuthorship W2893162207A5024484324 @default.
• W2893162207 hasAuthorship W2893162207A5035671675 @default.
• W2893162207 hasAuthorship W2893162207A5039628338 @default.
• W2893162207 hasAuthorship W2893162207A5043580027 @default.
• W2893162207 hasAuthorship W2893162207A5048248640 @default.
• W2893162207 hasAuthorship W2893162207A5049547284 @default.
• W2893162207 hasAuthorship W2893162207A5063586848 @default.
• W2893162207 hasAuthorship W2893162207A5073320477 @default.
• W2893162207 hasAuthorship W2893162207A5083882610 @default.
• W2893162207 hasAuthorship W2893162207A5087803133 @default.
• W2893162207 hasAuthorship W2893162207A5089477356 @default.
• W2893162207 hasBestOaLocation W28931622071 @default.
• W2893162207 hasConcept C126322002 @default.
• W2893162207 hasConcept C156957248 @default.
• W2893162207 hasConcept C1862650 @default.
• W2893162207 hasConcept C2776232647 @default.
• W2893162207 hasConcept C2777489490 @default.
• W2893162207 hasConcept C2777575956 @default.
• W2893162207 hasConcept C2779338263 @default.
• W2893162207 hasConcept C2779384505 @default.
• W2893162207 hasConcept C2780653079 @default.
• W2893162207 hasConcept C44249647 @default.
• W2893162207 hasConcept C71924100 @default.
• W2893162207 hasConcept C72563966 @default.
• W2893162207 hasConceptScore W2893162207C126322002 @default.
• W2893162207 hasConceptScore W2893162207C156957248 @default.
• W2893162207 hasConceptScore W2893162207C1862650 @default.
• W2893162207 hasConceptScore W2893162207C2776232647 @default.
• W2893162207 hasConceptScore W2893162207C2777489490 @default.
• W2893162207 hasConceptScore W2893162207C2777575956 @default.
• W2893162207 hasConceptScore W2893162207C2779338263 @default.
• W2893162207 hasConceptScore W2893162207C2779384505 @default.
• W2893162207 hasConceptScore W2893162207C2780653079 @default.
• W2893162207 hasConceptScore W2893162207C44249647 @default.
• W2893162207 hasConceptScore W2893162207C71924100 @default.
• W2893162207 hasConceptScore W2893162207C72563966 @default.
• W2893162207 hasIssue "1" @default.
• W2893162207 hasLocation W28931622071 @default.
• W2893162207 hasLocation W28931622072 @default.
• W2893162207 hasLocation W28931622073 @default.
• W2893162207 hasLocation W28931622074 @default.
• W2893162207 hasLocation W28931622075 @default.
• W2893162207 hasOpenAccess W2893162207 @default.
• W2893162207 hasPrimaryLocation W28931622071 @default.
• W2893162207 hasRelatedWork W2020711641 @default.
• W2893162207 hasRelatedWork W2028200430 @default.

• next